Skip to main content
NeuroThera Labs Inc. logo

NeuroThera Labs Inc. — Investor Relations & Filings

Ticker · NTLX ISIN · CA64136J1012 LEI · 529900GPL3C0DVADMS32 TSXV Manufacturing
Open in API
Filings indexed 145 across all filing types
Latest filing 2025-07-31 M&A Activity
Country CA Canada
Listing TSXV NTLX

About NeuroThera Labs Inc.

https://www.neurothera.com/

NeuroThera Labs Inc. is a clinical-stage company specializing in the development of therapeutics and advanced technologies for central nervous system (CNS) disorders and brain health. The company operates through two primary development streams. First, it is a leader in photobiomodulation (PBM) technology, developing drug-free, non-invasive devices for neurotherapy, targeting conditions such as Major Depressive Disorder (MDD), Alzheimer’s Disease, and Traumatic Brain Injury (TBI). Second, NeuroThera maintains a pharmaceutical pipeline focused on novel drug candidates, including programs based on THC and proprietary opioid/non-opioid compounds designed to enhance pain relief and treat CNS disorders. This dual approach leverages both advanced medical devices and clinical-stage drug candidates to address prevalent neurological conditions.

Recent filings

Filing Released Lang Actions
News release - English.pdf
M&A Activity Classification · 85% confidence The document is a corporate press release announcing an amendment to the letter of intent for a Qualifying Transaction between a capital pool company and SciSparc Ltd., extending the outside date for completion. This is an announcement related to a proposed merger/business combination. It does not present financial results, dividends, management changes, or share issuances, nor is it merely a publication notice. Therefore, it falls squarely under M&A Activity (Code: TAR).
2025-07-31 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 85% confidence The document is a CEO certificate (Form 52-109FV2) certifying the issuer’s interim financial report under Canadian NI 52-109. It is not the interim report itself and does not match other specific categories (e.g., audit report, earnings release, management discussion). Therefore it falls into the general regulatory filing fallback category.
2025-06-27 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 80% confidence The document is a Form 52-109FV2 Venture Issuer Basic Certificate by the CFO certifying the interim financial filing under Canadian NI 52-109. It is not the actual interim financial report (IR), nor an audit report (AR), nor an announcement of a report (RPA). It is a required regulatory disclosure attachment, which best fits the fallback category for general regulatory filings (RNS).
2025-06-27 English
Interim MD&A - English.pdf
Management Reports Classification · 95% confidence The document is titled “Management Discussion and Analysis” for the quarter ended April 30, 2025 and contains forward-looking statements, narrative analysis of operations, liquidity, capital resources, risks, and related party transactions. It does not include the full financial statements themselves but is the management’s commentary on quarterly results. This matches the definition for Management Reports (MDA).
2025-06-27 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive set of unaudited interim financial statements for Miza III Ventures Inc. for the three-month period ended April 30, 2025. It includes a Statement of Financial Position, Statement of Loss and Comprehensive Loss, Statement of Shareholders' Equity, Statement of Cash Flows, and detailed Notes to Financial Statements. It is not an announcement or a summary, but the full financial report for an interim period, fitting the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-06-27 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings
2025-05-30 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.